Tenelia Elderly CGMS Study(TEDDY)

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

NCT00280865 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

NCT02305381 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

NCT04465396 ·Status: COMPLETED ·Phase: PHASE1

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

NCT00354536 ·Status: COMPLETED ·Phase: PHASE2

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

NCT00761540 ·Status: COMPLETED ·Phase: PHASE1

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

NCT06559722 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus

NCT04050553 ·Status: COMPLETED ·Phase: PHASE1

A Study of CT-868 in Type 1 Diabetes Mellitus

NCT06062069 ·Status: COMPLETED ·Phase: PHASE2

GALLANT 22 Tesaglitazar vs. Placebo

NCT00252837 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

NCT03051243 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

NCT07282054 ·Status: COMPLETED ·Phase: PHASE3

Linagliptin as Add on to Basal Insulin in the Elderly

NCT02240680 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

NCT07282743 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

NCT02098395 ·Status: COMPLETED ·Phase: PHASE3

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

NCT06783309 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

NCT01490762 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3305677 in Participants With Type 2 Diabetes

NCT03928379 ·Status: COMPLETED ·Phase: PHASE1

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus

NCT00521378 ·Status: COMPLETED

Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus

NCT01236404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

NCT07088068 ·Status: RECRUITING ·Phase: PHASE3

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

NCT04596631 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

NCT00603239 ·Status: COMPLETED ·Phase: PHASE3

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

NCT00229710 ·Status: TERMINATED ·Phase: PHASE3

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT00387972 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes

NCT00511732 ·Status: COMPLETED ·Phase: PHASE2